Palisade Capital Management’s NantHealth, Inc NH Stock Holding History

Palisade Capital Management’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,733	Closed	-$42K	–	453
2019 Q4	$42K	Hold	2,733	–	–	﹤0.01%	410
2019 Q3	$29K	Hold	2,733	–	–	﹤0.01%	422
2019 Q2	$22K	Hold	2,733	–	–	﹤0.01%	409
2019 Q1	$38K	Sell	2,733 -267	-9%	-$3.09K	﹤0.01%	431
2018 Q4	$24K	Buy	3,000 +400	+15%	+$7.01K	﹤0.01%	443
2018 Q3	$61K	Buy	2,600 +67	+3%	+$2.55K	﹤0.01%	458
2018 Q2	$126K	Buy	+2,533	New	+$125K	﹤0.01%	449

Other funds holding NH

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Palisade Capital Management's NH Position: Q1 2020 in Review

Palisade Capital Management sold out of NantHealth, Inc (NH) in Q1 2020, closing a stake of 2,733 shares — an estimated $42K sold.

Palisade Capital Management first reported a position in NH in Q2 2018 and held it in 7 quarters. The position peaked at $126K in Q2 2018. 29 funds tracked by Wall St. Rank hold NH as of Q1 2020.

Palisade Capital Management reported no remaining NantHealth, Inc position as of Q1 2020 after selling out during the quarter.
Palisade Capital Management sold 2,733 NantHealth, Inc shares in Q1 2020, an estimated $42K.
Palisade Capital Management first reported a position in NantHealth, Inc in Q2 2018 and held it in 7 quarters.
Palisade Capital Management's NantHealth, Inc position peaked at $126K in Q2 2018.
29 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2020.

Based on Palisade Capital Management's 13F filing for Q1 2020, filed 13 May 2020.